Efficacy of Myofascial Induction as a Manual Therapy Technique in Patients With Anxiety

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-20

Study Completion Date

2022-07-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the efficacy of a myofascial intervention as a technique within manual therapy in the treatment of clinical anxiety in adults. Half of the participants will receive a myofascial intervention program, while the other half will receive a sham myofascial intervention.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.

NCT01250184

Myofascial Pain Syndrome Pain Myofascial Trigger Point Pain +1 more

COMPLETED PHASE4

Myofascial Pain and Central Sensitization

NCT04929171

Myofascial Pain Physical Therapy

COMPLETED

Clinical Outcomes After Dry Needling on Cervical Muscles, and Quality of Life, in Patients With Fibromyalgia Syndrome.

NCT03015662

Fibromyalgia

COMPLETED NA

Immediate Stiffness Changes in Myofascial Trigger Points After Dry Needling

NCT04832074

Myofascial Pain Syndrome Neck Pain Trigger Point Pain, Myofascial

COMPLETED NA

Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain

NCT06723821

COVID-19 Musculoskeletal Pain

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Within physiotherapy, some studies have been carried out with psychological outcome measures, mainly from therapeutic exercise, but there continues to be an important documentary gap and the few results are not conclusive.

The myofascial approach is presented as an effective tool for the treatment of different pathologies, mainly musculoskeletal. However, few are the studies that relate it to psychological variables and specifically to improve anxiety levels.

The myofascial approach is proposed as a fast and low-cost tool for the management of clinical anxiety.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A randomized double blind clinical trial controlled with placebo in which neither the participants assigned to the groups nor the evaluators who measure the variables know to which group the subjects belong.

To be part of the study, participants must obtain high scores in anxiety (STAI questionnaire).

The calculation estimates a sample of 36 participants: 18 for the experimental group and 18 for the placebo group.

Participants will be randomly assigned to the experimental group or the placebo group.

In addition to anxiety levels before and after treatment, variables such as chronic pain, central sensitization, general health, somatization and depression will be measured.

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Patients will be assigned to two groups:

* Experimental group: who will receive myofascial intervention
* Control / placebo group: who will receive sham myofascial intervention

Neither the participants assigned to the groups nor the evaluators who measure the variables know to which group the subjects belong.

Participants will be randomly assigned through the GraphPad software.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Myofascial treatment

4 sessions of myofascial intervention, 40 minutes per session, 1 session per week

Group Type EXPERIMENTAL

Myofascial treatment

Intervention Type OTHER

40 minutes of myofascial intervention: 10 min in each of the following regions with the patient face up:

* Thoracolumbar fascia and abdomen
* C7-T4 and sternum
* Suboccipital area
* Temporary area

Sham myofascial treatment

4 sessions of sham myofascial intervention, 40 minutes per session, 1 session per week

Group Type SHAM_COMPARATOR

Sham myofascial treatment

Intervention Type OTHER

40 minutes of sham myofascial intervention: 10 min in each of the following regions with the patient face up and with the contact of the physiotherapist through a towel and without any intention:

* Thoracolumbar fascia and abdomen
* C7-T4 and sternum
* Suboccipital area
* Temporary area

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Myofascial treatment

40 minutes of myofascial intervention: 10 min in each of the following regions with the patient face up:

* Thoracolumbar fascia and abdomen
* C7-T4 and sternum
* Suboccipital area
* Temporary area

Intervention Type OTHER

Sham myofascial treatment

40 minutes of sham myofascial intervention: 10 min in each of the following regions with the patient face up and with the contact of the physiotherapist through a towel and without any intention:

* Thoracolumbar fascia and abdomen
* C7-T4 and sternum
* Suboccipital area
* Temporary area

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be between 18 and 65 years old
* Subjects with high levels of anxiety
* Subjects who speak and understand Spanish correctly
* Subjects without previous experience in myofascial treatment

Exclusion Criteria

* Subjects with a clinical history of cognitive impairment
* Subjects with systemic, neurological or muscular diseases
* Subjects with some type of aneurysm diagnosed
* Subjects with diagnosed extremely high blood pressure
* Subjects with diagnosed malignant tumors
* Subjects with diagnosed vertebrobasilar insufficiency
* Subjects with a diagnosed dermatological condition
* Subjects diagnosed with epilepsy
* Pregnant women or with the possibility that they may be

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No